These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7988037)

  • 21. Immunohistochemical localisation of pS2 protein in ductal carcinoma in situ and benign lesions of the breast.
    Luqmani YA; Campbell T; Soomro S; Shousha S; Rio MC; Coombes RC
    Br J Cancer; 1993 Apr; 67(4):749-53. PubMed ID: 8385977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a highly sensitive sandwich enzyme immunoassay for human ferritin using affinity-purified anti-ferritin labelled with beta-D-galactosidase from Escherichia coli.
    Imagawa M; Yoshitake S; Ishikawa E; Niitsu Y; Urushizaki I; Kanazawa R; Tachibana S; Nakazawa N; Ogawa H
    Clin Chim Acta; 1982 Jun; 121(3):277-89. PubMed ID: 6809359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression of pS2 protein in breast cancer and its relationship with estrogen and progesterone receptors].
    Díez Gibert O; Machuca I; Sebastián MA; Rosel P; Navarro MA
    Med Clin (Barc); 1996 Jun; 107(3):90-2. PubMed ID: 8754494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of antibody IgG to HIV-1 in urine by sensitive enzyme immunoassay (immune complex transfer enzyme immunoassay) using recombinant proteins as antigens for diagnosis of HIV-1 infection.
    Hashida S; Hirota K; Hashinaka K; Saitoh A; Nakata A; Shinagawa H; Oka S; Shimada K; Mimaya J; Matsushita S
    J Clin Lab Anal; 1993; 7(6):353-64. PubMed ID: 7506305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. pS2 protein status fails to be an independent prognostic factor in an average breast cancer population.
    Speiser P; Stolzlechner J; Haider K; Heinzl H; Jakesz R; Pecherstorfer M; Rosen H; Sevelda P; Zeilliger R
    Anticancer Res; 1994; 14(5B):2125-30. PubMed ID: 7840511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the breast cancer-associated protein pS2 in adenosquamous carcinomas of the gastrointestinal tract.
    Welter C; Seitz G; Blin N
    Acta Oncol; 1993; 32(3):315-7. PubMed ID: 8323770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer.
    Pujol P; Daurès JP; Brouillet JP; Maudelonde T; Rochefort H; Grenier J
    Br J Cancer; 1999 Feb; 79(5-6):909-14. PubMed ID: 10070889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer.
    Daffada AA; Johnston SR; Smith IE; Detre S; King N; Dowsett M
    Cancer Res; 1995 Jan; 55(2):288-93. PubMed ID: 7812959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzyme immunoassay of angiotensin II in human plasma.
    Yasunaga F; Kawano A; Morikawa N; Takeyama M
    Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):792-4. PubMed ID: 1611694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of antibody IgG to HIV-1 in urine by ultrasensitive enzyme immunoassay (immune complex transfer enzyme immunoassay) using recombinant p24 as antigen for diagnosis of HIV-1 infection.
    Hashida S; Hashinaka K; Hirota K; Saitoh A; Nakata A; Shinagawa H; Oka S; Shimada K; Mimaya J; Matsushita S
    J Clin Lab Anal; 1994; 8(2):86-95. PubMed ID: 8189327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of cytosolic concentrations of ER, PS2, Cath-D, TPS, TK and cAMP in primary breast carcinomas.
    Kausitz J; Kuliffay P; Pecen L; Eben K; Puterová B
    Neoplasma; 1994; 41(6):331-6. PubMed ID: 7870216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimation of serum level of pS2 protein in patients with lung adenocarcinoma.
    Higashiyama M; Doi O; Kodama K; Yokuchi H; Inaji H; Tateishi R
    Anticancer Res; 1996; 16(4B):2351-5. PubMed ID: 8694568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [pS2 protein and breast cancer].
    Torre EA; Fulco RA
    Minerva Ginecol; 1995 Dec; 47(12):553-6. PubMed ID: 8720977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intestinal trefoil factor (TFF 3) and pS2 (TFF 1), but not spasmolytic polypeptide (TFF 2) mRNAs are co-expressed in normal, hyperplastic, and neoplastic human breast epithelium.
    Poulsom R; Hanby AM; Lalani EN; Hauser F; Hoffmann W; Stamp GW
    J Pathol; 1997 Sep; 183(1):30-8. PubMed ID: 9370944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Estrogen receptor studies in breast cancer based on histological material. Correlation with results from needle biopsy aspirates and pS2 protein determination].
    Sauer T; Naess O
    Tidsskr Nor Laegeforen; 1995 Sep; 115(23):2881-3. PubMed ID: 7570508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the pS2 peptide in primary breast carcinomas: comparison of membrane and cytoplasmic staining patterns.
    Dookeran KA; Rye PD; Dearing SJ; Walker RA
    J Pathol; 1993 Oct; 171(2):123-9. PubMed ID: 8283349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of relapse and survival in breast cancer patients by pS2 protein status.
    Foekens JA; Rio MC; Seguin P; van Putten WL; Fauque J; Nap M; Klijn JG; Chambon P
    Cancer Res; 1990 Jul; 50(13):3832-7. PubMed ID: 2354435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of pS2 protein in pancreatic cyst fluids. Evidence for a potential role of pS2 protein in the pathogenesis of mucinous cystic tumors.
    Yang JM; Lee J; Southern JF; Warshaw AL; Dhanak E; Lewandrowski KB
    Int J Pancreatol; 1998 Dec; 24(3):181-6. PubMed ID: 9873952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical detection of sex steroid receptors in breast cancer using routine paraffin sections: comparison with frozen sections and enzyme immunoassay.
    Elias JM; Margiotta M; Sexton TR; Heimann A
    J Cell Biochem Suppl; 1994; 19():126-33. PubMed ID: 7823584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of the estrogen-regulated proteins, cathepsin-D and pS2, in breast cancer.
    Fulco RA; Petix M; Salimbeni V; Torre EA
    Minerva Med; 1998; 89(1-2):5-10. PubMed ID: 9561019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.